Determinants of revision and functional outcome following unicompartmental knee replacement  by Liddle, A.D. et al.
Osteoarthritis and Cartilage 22 (2014) 1241e1250Determinants of revision and functional outcome following
unicompartmental knee replacement
A.D. Liddle y *, A. Judge z, H. Pandit y, D.W. Murray y
y Nufﬁeld Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford
OX3 7LD, UK
z NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, and MRC Lifecourse Epidemiology Unit, University of Southampton, Botnar Research
Centre, Windmill Road, Oxford OX3 7LD, UKa r t i c l e i n f o
Article history:
Received 1 April 2014





Arthroplasty* Address correspondence and reprint requests to:
Orthopaedics, Rheumatology and Musculoskeletal
Centre, Windmill Road, Oxford OX3 7LD, UK. Tel: 44
227671.
E-mail addresses: Alexander.liddle@ndorms.ox.a
judge@ndorms.ox.ac.uk (A. Judge), Hemant.pandit@
David.murray@ndorms.ox.ac.uk (D.W. Murray).
http://dx.doi.org/10.1016/j.joca.2014.07.006
1063-4584/© 2014 The Authors. Published by Elsevie
creativecommons.org/licenses/by/3.0/).s u m m a r y
Objective: Unicompartmental Knee Replacement (UKR) has important advantages over total knee
replacement (TKR) but has a higher revision rate. Outcomes vary between centres, suggesting that risk
factors for revision may be modiﬁable with changes to patient selection or operative technique. The
objective of this study was to determine factors affecting revision, patient-reported outcome and
satisfaction following UKR.
Method: 25,982 cases from three national databases were analysed. Multilevel multivariable regression
models were used to examine the effect of patient and surgical factors on implant survival, patient-
reported outcome and satisfaction at 6 months and 8 years following UKR.
Results: Of the 25,982 cases, 3862 (14.9%) had pre-operative and 6-month Oxford Knee Scores (OKS).
Eight-year survival was 89.1% (95% conﬁdence intervals (CI) 88.3e89.9). OKS increased from 21.9 (SD 7.6)
to 37.5 (SD 9.5). Age (Hazard ratio (HR) 0.96 (95% CI 0.96e0.97) per year), male gender (HR 0.86 (95% CI
0.76e0.96)), unit size (HR 0.92 (95% CI 0.86e0.97) per case up to 40 cases/year) and operating surgeon
grade (HR 0.78 (95% CI 0.67e0.91) if consultant) predicted improved implant survival. Older patients
(75 years), and those with lower deprivation levels had superior OKS and satisfaction (adjusted mean
difference 0.14 (95% CI 0.09e0.20) points per year of age and 0.93 (95% CI 0.60e1.27) per quintile of
deprivation). Ethnicity, anxiety and co-morbidities also affected patient-reported outcome.
Conclusions: This study has identiﬁed important predictors of revision and patient-reported outcome
following UKR. Older patients, who are least likely to be offered UKR, may derive the greatest beneﬁts.
Improved understanding of these factors may improve the long-term outcomes of UKR.
© 2014 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).Introduction
Unicompartmental Knee Replacement (UKR) comprises be-
tween 5% and 10% of all knee replacements recorded each year in
national joint registries (NJRs), but up to 50% may be eligible on the
basis of disease pattern1e4. By only replacing the damaged parts of
the knee, preserving normal structures such as the anterior cruciate
ligament (ACL), UKR restores normal knee kinematics, restoringA.D. Liddle, Nufﬁeld Dept. of
Sciences, Botnar Research
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c.uk (A.D. Liddle), Andrew.
ndorms.ox.ac.uk (H. Pandit),
r Ltd and Osteoarthritis Research Smore normal knee function than is possible with total knee
replacement (TKR)5,6. Patients undergoing UKR recover more
quickly, and have less perioperative morbidity and mortality
compared to TKR, probably due to the reduced soft tissue disrup-
tion and blood loss in UKR7e9. However, surgeons are discouraged
from using UKR as the reported revision rate is signiﬁcantly higher
than that of TKR2. This varies between units, due to differences in
patient selection, surgical practice and threshold for revision of
poorly-functioning implants. If predictive factors are identiﬁed and
addressed, there is the potential to improve the revision rate of UKR
to an acceptable level, allowing more patients to beneﬁt from the
advantages associated with UKR.
The factors predicting outcomes in TKR have been extensively
studied10e19. Amongst others, youth and male gender appear to
predict revision16, whilst female gender, anxiety/depression and
deprivation predispose to poor patient-reported outcomes andociety International. This is an open access article under the CC BY license (http://
A.D. Liddle et al. / Osteoarthritis and Cartilage 22 (2014) 1241e12501242dissatisfaction with surgery13,17,19,20. There is conﬂicting evidence
about the importance of body mass index (BMI), with some studies
suggesting that it affects outcome11,17, and others reporting no ef-
fect13,21. The extent to which these factors affect the outcome of
UKR is uncertain.
As a result, there is great variation of practice regarding UKR,
with some surgeons offering it to all patients who have suitable
pathoanatomy, and others restricting access to UKR on the basis of
criteria including age, activity level or BMI22,23. The aim of this
study is to identify factors predisposing to poor outcomes following




The NJR for England, Wales and Northern Ireland contains de-
tails on all knee, hip and ankle replacements performed each year
in both public and private hospitals in England, Wales and, since
2012, Northern Ireland. Since 2011, data collection has been
mandatory2. Data recorded in the NJR includes prosthesis and
operative information (including prosthesis type, approach and
thromboprophylaxis use); patient information (age, gender, BMI,
American Society of Anaesthesiologists (ASA) grade); surgical and
unit information (including surgeon and unit caseload and public/
private status)2. The Hospital Episode Statistics (HES) database re-
cords details of all hospital admissions in England. It covers a
smaller geographical area than the NJR (excluding patients oper-
ated upon in Wales and Northern Ireland), and does not include
privately-funded operations. However, it provides additional in-
formation, including detailed information on co-morbidities and
deprivation. Since April 2009, Patient-Reported Outcome Measure
(PROM) data has been collected on hip and knee replacements
performed in public hospitals in England. Pre-operative and
6 month quality of life questionnaires (the EuroQol ﬁve domain
(EQ5D)24) and joint-speciﬁc PROMs (for the knee, the Oxford Knee
Score (OKS)25) are collected along with patient-reported measures
of preoperative disability and post-operative satisfaction.
Using an extract of data from the NJR, all patients who under-
went UKR between 2003 and August 2012 were identiﬁed
(n¼ 41,986). Using unique identiﬁers, these patients were linked to
corresponding HES records. Given the smaller population covered
by HES, 25,982/41,986 NJR records could be linked (62%); these
patients formed the study group. Given the substantially shorter
time that the PROM database has been active, only 3862 of the
25,982 patients (14.9%) were linked to complete (i.e., pre- and post-
operative) PROM records.
Outcomes of interest
Primary outcome measures were revision, patient-reported
outcome and satisfaction. Revision was deﬁned as the removal,
exchange or addition of any of the components of arthroplasty and
was assessed using survival analysis techniques. Patient-reported
outcome was assessed using the OKS. The OKS is a patient-
completed questionnaire which assesses twelve domains of knee
pain and function, each rated from zero (the worst score) to four
(the best), completed using Likert scales25. It was examined in two
ways, ﬁrstly, as a continuous score ranging 0e4826, and secondly, as
a binary outcome representing patients whose OKSwas worse after
surgery than before. This method identiﬁes patients who experi-
ence very poor outcomes but who do not (either through frailty or
patient choice) receive revision surgery. Finally, satisfaction with
surgery was rated on the basis of the question: “How would youdescribe the results of your operation?”, answered on a ﬁve-point
scale from 1 (poor) to 5 (excellent).Exposures
Exposures included patient and surgical factors. Patient factors
included demographics (age, gender, ethnicity); and health state
(BMI, Charlson co-morbidity index and ASA grade). Pre-operative
function was assessed using the OKS and EQ5D. The EQ5D con-
sists of ﬁve questions (assessing mobility, self-care, ability to
conduct usual activities, degree of pain/discomfort, and degree of
anxiety/depression), ranging from 1 (best state) to 3 (worst state).
EQ5D can be expressed as an overall index (graded from 0.594 to
1), or as ordinal responses for each category. Pre-operatively, pa-
tients rate their general health on a ﬁve-point Likert scale fromvery
poor to excellent, and to report whether they considered them-
selves to suffer from a disability (yes or no).
Ethnicity (as reported by the patient) was grouped into six
categories. These are: White (White British, White Irish and other);
Mixed Ethnicity; Asian (Indian, Pakistani, Bangladeshi and other);
Black (Caribbean, African and other); Other (including Chinese);
and Not Given. This categorisation has been used in other PROM
studies27.
Deprivation was assessed using the Index of Multiple Depriva-
tion (IMD), a UK governmental assessment of the level of depri-
vation by area28. The IMD assesses 37 indicators, divided up into
seven domains (Income, employment, health and disability, edu-
cation, barriers to housing and services, living environment, and
crime). On the basis of these indicators, all 32,482 areas are ranked;
for this study, IMD was grouped by national quintiles, higher
quintiles being less deprived.
Surgical factors included unit type (whilst all the cases in this
cohort were publically funded, they may be performed in public or
private hospitals, or in independent-sector treatment centres
(ISTC)); unit size (number of cases performed per unit per year);
and type of thromboprophylaxis (chemical or mechanical).
Categorisation of continuous variables was avoided wherever
possible; the exception was made for non-linear predictors with
established groupings (e.g., BMI)29. Where datasets were incom-
plete, the degree and pattern of missingness was assessed and, if
appropriate, missing values were completed using multiple impu-
tation (MI, see Statistical Appendix).Statistical analysis
Predictors of implant survival were examined using Cox
regression. Univariable and multivariable models were ﬁtted.
Clustering by surgeon was accounted for by using cluster-robust
standard errors. Sensitivity analyses included the use of Fine and
Gray models to account for the competing risk of death (see
Statistical Appendix)30. Survival analyses were censored at 8 years.
For continuous PROM outcomes, analysis of covariance
(ANCOVA) was used. This allows examination of the effect of pre-
dictors on the OKS whilst accounting for baseline differences in
OKS between patients31. Again, both univariable and multivariable
models were constructed. Clustering by surgeonwas accounted-for
using a two-level random intercept model. As the multivariable
model used data completed using MI, explained variation was
assessed by calculating the adjusted R2 using the method described
by Harel32.
For the binary PROM outcome (improvement/no change in OKS
vs deterioration), logistic regression was used; again, univariable
andmultivariable models were used and clustering was accounted-
for using a two-level random intercept model. Ordered logistic
Table I
Baseline characteristics of the group
Number of patients (% of total) Whole group Patients with PROMs
25,982 (100) 3862 (14.9)
Variable Mean (SD, Range)
Age 64.3 (9.7, 21.7e95.8) 64.1 (9.3, 29.2e90.9)
BMI; 13,441 (52%) missing 30.2 (5.0, 16e60) 30.0 (4.9, 16e56)
Unit size 49.4 (60.9, 1e317) 55.1 (64.2, 1e317)
Variable N (%)
Gender (male) 13,547 (52.1) 2004 (51.9)
ASA grade 1 5885 (22.7) 875 (22.7)
2 17,725 (68.2) 2695 (69.8)
3þ 2372 (9.1) 292 (7.6)
Ethnicity Un-deﬁned 3654 (14.1) 401 (10.4)
White 21,506 (82.8) 3,370 (87.3)
Mixed race 54 (0.2) 10 (0.3)
Asian 515 (2.0) 47 (1.2)
Black 120 (0.5) 12 (0.3)
Other 133 (0.5) 22 (0.6)
Unit type NHS Hospital 22,085 (85.0) 3092 (80.1)
Private hospital 2872 (11.1) 593 (15.4)
ISTC 1025 (4.0) 177 (4.6)
Consultant performed 22,255 (85.7) 3352 (86.8)
Mechanical thrombo-prophylaxis TEDs 16,772 (64.6) 2607 (67.5)
Foot pumps/calf compression 5820 (22.4) 981 (25.4)
Other 272 (1.1) 34 (0.9)
None 3118 (12.0) 240 (6.2)
Chemical thrombo-prophylaxis Heparin/LMWH 15,816 (60.9) 2406 (62.3)
Aspirin 3924 (15.1) 374 (9.7)
Warfarin 211 (0.8) 31 (0.8)
Direct Thrombin Inhibitor 1101 (4.2) 297 (7.7)
Other 1927 (7.4) 507 (13.1)
None 3003 (11.6) 247 (6.4)
Implant ﬁxation (cemented) 23,209 (90.0) 3368 (87.7)
Charlson co-morbidity index None 20,865 (80.3) 3038 (78.7)
Mild 4298 (16.5) 715 (18.5)
Moderate 642 (2.5) 92 (2.4)
Severe 177 (0.7) 17 (0.4)
IMD (Quintiles) 1 (most deprived) 2951 (11.4) 364 (9.4)
2 4361 (16.8) 592 (15.3)
3 5791 (22.3) 836 (21.7)
4 6179 (23.8) 971 (25.1)
5 (least deprived) 6700 (25.8) 1099 (28.5)
Pre-operative OKS 21.9 (7.6, 0e43) 21.9 (7.6, 0e43)
Pre-operative EuroQol 5 domain score (EQ5D) 0.480 (0.290, 0.426 to 1) 0.480 (0.290, 0.426 to 1)
Pre-operative EQ5D anxiety/depression None 2331 (68.0) 2331 (68.0)
Moderate 1002 (29.2) 1002 (29.2)
Extreme 96 (2.8) 96 (2.8)
Self-reported health Excellent 133 (4.9) 133 (4.9)
Very good 894 (33.0) 894 (33.0)
Good 1209 (44.7) 1209 (44.7)
Fair 413 (15.3) 413 (15.3)
Poor 58 (2.1) 58 (2.1)
Self-reported disability 1347 (41.2) 1347 (41.2)
TEDS e Thromboembolic Deterrent Stockings; LMWH e Low Molecular Weight Heparin. Self-reported health and disability are additional questions on the pre-op PROM
questionnaire and are not part of EQ5D.
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on satisfaction.Regression diagnostics
The linearity of the effect of each exposure was assessed using
two techniques. For survival analyses, fractional polynomial plots
were produced to characterise the survival hazard33. For PROM
(linear regression) analyses, scatterplots were produced and
smoothed curves ﬁtted using locally-weighted scatterplot
smoothing (LOWESS). For non-linear predictors with established
categories (such as BMI), categorisationwas used; otherwise, linear
splines were ﬁtted to break the hazard down into linear sub-
sections; these were entered separately into the model. In-
teractions were examined; in the case of a continuousecontinuousinteractionwith a non-linear predictor, fractional polynomials were
ﬁtted and interactions detected using the user-written ‘mfpigen’
command in Stata34.
Collinearity was assessed by checking the variance inﬂation
factor after running each model. Normality of residuals was
assessed by plotting standardised normal probabilityeprobability
plots. Heteroskedasticity was assessed using graphical examination
of residuals. All statistical analyses were performed using Stata IC
v.12.1 for Windows (Stata Corp., College Station, TX).Results
Overall implant survival was 91.8% (95% conﬁdence intervals (CI)
91.3e92.3) at 5 years and 89.1% (95% CI 88.3e89.9) at eight. OKS
increased from 21.9 (SD 7.6) points preoperatively to 37.5 (SD 9.5)
Table II
Overall outcomes (patient demographics and pre-operative scores given in Table I)
Outcome
8-year implant survival (95% CI) 89.1 (88.3e89.9)
6-month OKS, mean (SD) 37.5 (9.5)
6-month EQ5D, mean (SD) 0.770 (0.250)
Improvement, N (%) Better 3,204 (93.4)
Same 37 (1.1)
Worse 188 (5.48)
Satisfaction, N (%). Excellent 930 (27.1)




Not given 13 (0.4)
A.D. Liddle et al. / Osteoarthritis and Cartilage 22 (2014) 1241e12501244points at 6 months. EQ5D index increased from a mean score of
0.480 (SD 0.290) preoperatively to 0.770 (SD 0.250) at 6 months.
84.3% of patients had good, very good or excellent levels of satis-
faction. 5.5% of patients had worse OKS at 6 months than before-
hand and 3.8% reported poor satisfaction. Full datasets were
available for all exposures of interest except BMI which exhibited a
high level of missing data. Missing BMI data were substituted using
MI. The process of MI is described in detail in the statistical ap-
pendix. Descriptive statistics are displayed in Table I; outcomes are
given in Table II. A KaplaneMeier plot of overall implant survival is
given in Fig. 1.Regression diagnostics
No evidence of collinearity was demonstrated for any of the
models. The distribution of residuals was not demonstrated to
deviate signiﬁcantly from normality. Heteroskedasticity was
demonstrated in the continuous OKS comparison; robust standard
errors were employed with the sandwich variance estimator.
Linearity of predictors is considered in the following sections.Factors affecting implant survival (Table III)
Implant survival was better in older people, men, and those
with no co-morbidities (compared to those with moderate co-
morbidities). Revision was less likely if the procedure was per-
formed in a larger unit and if it was performed by a consultantFig. 1. KaplaneMeier plot demonstrating overall implant survival.rather than a trainee. The effect of unit size was non-linear,
reducing markedly up to 40 cases/year before reaching a
plateau. There was a trend towards inferior survival in ISTC
compared to NHS hospitals, and with higher levels of depriva-
tion, but these had only borderline signiﬁcance. Neither BMI,
ethnicity, nor thromboprophylaxis had any effect on implant
survival. Survival was equivalent for cemented and cementless
UKR.
Factors affecting PROMs and satisfaction (Table IV)
Pre-operative OKS had a strong positive effect on 6-month OKS.
Age strongly affected both pre-and post-operative OKS in a non-
linear fashion. For both pre- and post-operative OKS, scores
peaked at around 75 years of age (Fig. 2). Two linear splines were
ﬁtted, one up to 75 years and one beyond 75 years. Up to the age of
75, age had a signiﬁcant positive effect on 6-month OKS (0.14 points
per year, P < 0.001). Above 75, scores reduced but this did not reach
statistical signiﬁcance. These ﬁndings were adjusted for the
observed baseline differences in OKS. In addition, older patients
were less likely to have worse scores at 6 months than pre-
operatively, and were more likely to be satisﬁed.
An interaction was detected between the effects of age and pre-
operative OKS level. Young patients with very poor preoperative
scores appeared to fare particularly poorly: whilst poorly-
functioning patients (i.e., those with a preoperative OKS 15)
above the age of 65 can expect to gain 22.5 points on their pre-
operative OKS (95% CI 21.3e23.8), those below the age of 65 can
only expect to gain 18.8 points (95% CI 17.7e19.8). The difference
between patients above and below the age of 65 disappears for
higher pre-operative OKS values (Fig. 3). No other interactions were
detected.
To explore this further, the model was stratiﬁed into patients
with poor pre-operative OKS (15) and those with better pre-
operative OKS (>15); the results of these analyses are given in the
statistical appendix. The stratiﬁcation was not observed to affect
the effect sizes or signiﬁcance levels for any of the other variables
studied and the non-stratiﬁed model is presented (Table IV).
Ethnicity appeared to affect outcome, with Black and Asian
patients reporting signiﬁcantly worse OKS and satisfaction. Pa-
tients were less likely to deteriorate and more likely to be satisﬁed
if their operation was performed by a consultant rather than a
trainee; whilst there was a trend to higher overall scores in
consultant-performed cases, this was not statistically signiﬁcant.
Unit size did not have as great an effect on patient-reported
outcome as it did on implant survival. The effect of unit size on
6-month OKS was again non-linear; OKS improved by 0.32 points
for every ten cases up to 40, before becoming essentially constant
above 40 cases. Only borderline signiﬁcance was achieved in
either section. There was a small but statistically signiﬁcant in-
crease in satisfaction if the case was performed in a higher-
volume unit.
Those with co-morbidities (measured by the Charlson index)
were more likely to have worse scores at 6 months than pre-
operatively; patients who reported poor health prior to surgery
or who described themselves as having a disability, had worse
outcomes by all three metrics. Overall, thromboprophylaxis did not
exert a great effect on patient-reported outcome, with the excep-
tion of patients taking aspirin, who were more likely to report
deterioration in their OKS, as well as having a trend to lower overall
OKS and satisfaction.
Better pre-operative OKS predicted better post-operative OKS,
but patients with higher pre-op scores had a higher chance of
having a worse 6 month score than they had beforehand. Very few
patients underwent UKR with an OKS of more than 35 points
Table III
Univariable and multivariable survival models. HR are given for all-cause revision up to 8 years following surgery
Variable Univariable Multivariable
HR (±95 CI) Signiﬁcance HR (±95 CI) Signiﬁcance
Age (linear, per year) 0.96 (0.96e0.97) <0.01 0.96 (0.96e0.97) <0.01
Gender (male) 0.83 (0.74e0.94) <0.01 0.86 (0.76e0.96) 0.01
ASA (per one grade increase) 0.94 (0.85e1.05) 0.27 1.06 (0.95e1.20) 0.30
BMI (per unit, n ¼ 13,501) 1.02 (1.00e1.04) 0.05 1.01 (0.98e1.03) 0.59
Ethnic group e white Reference
un-deﬁned 0.86 (0.72e1.02) 0.09 0.86 (0.72e1.02) 0.08
Mixed race 0.42 (0.07e2.65) 0.36 0.34 (0.05e2.24) 0.26
Asian 0.94 (0.60e1.46) 0.77 0.81 (0.52e1.25) 0.34
Black 1.39 (0.71e2.72) 0.33 1.02 (0.50e2.06) 0.96
Other 0.39 (0.09e1.61) 0.19 0.39 (0.09e1.61) 0.19
Unit type e NHS hospital Reference
Independent hospital 1.07 (0.88e1.30) 0.51 1.07 (0.87e1.30) 0.53
ISTC 1.10 (0.78e1.55) 0.59 1.43 (0.99e2.05) 0.05
Consultant performed 0.91 (0.77e1.07) 0.24 0.78 (0.67e0.91) <0.01
Mechanical thrombo-prophylaxis TEDS Reference
Foot pumps 1.02 (0.84e1.23) 0.87 0.98 (0.81e1.19) 0.82
Other 1.32 (0.80e2.18) 0.27 1.24 (0.77e2.01) 0.37
None 1.04 (0.85e1.27) 0.70 1.01 (0.83e1.22) 0.94
Chemical thrombo-prophylaxis Heparin/LMWH Reference
Aspirin 0.98 (0.79e1.22) 0.85 1.11 (0.90e1.37) 0.34
Warfarin 0.61 (0.30e1.26) 0.18 0.71 (0.35e1.44) 0.34
DTI 0.56 (0.30e1.04) 0.07 0.55 (0.30e1.01) 0.06
Other 0.86 (0.63e1.18) 0.36 0.81 (0.59e1.11) 0.19
None 1.15 (0.93e1.43) 0.20 1.22 (0.98e1.51) 0.08
Fixation 0.99 (0.77e1.26) 0.91 1.02 (0.79e1.31) 0.89
Charlson e No comorbidities Reference
Mild comorbidities 1.09 (0.94e1.27) 0.26 1.12 (0.96e1.30) 0.16
Moderate comorbidities 1.36 (0.95e1.95) 0.09 1.49 (1.04e2.12) 0.03
Severe comorbidities 1.21 (0.62e2.35) 0.58 1.40 (0.72e2.72) 0.33
IMD (per quintile) 0.91 (0.87e0.96) <0.01 0.96 (0.91e1.00) 0.07
Unit size (per ten cases) Up to 40 cases/yr 0.97 (0.96e0.99) <0.01 0.92 (0.86e0.97) 0.01
Above 40 cases/yr 0.99 (0.97e1.01 0.32
LMWH e low molecular weight heparin; DTI e direct thrombin inhibitor.
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being worse post-operatively than preoperatively; the chance of
deterioration was only 5.1% in patients with a preoperative OKS of
35 points or fewer. Patients with extreme anxiety or depression (as
measured using the EQ5D) had signiﬁcantly worse scores overall
compared to those with no anxiety/depression, but were no more
likely to deteriorate or to be dissatisﬁed. Neither BMI, ASA grade,
unit type, nor implant ﬁxation had any effect on outcome by any
measure.
Discussion
This study has demonstrated UKR to be a highly effective
intervention in relieving the symptoms of end-stage osteoarthritis.
However, important risk factors for failure, in terms of patient se-
lection and surgical practice, have been identiﬁed. Whilst there is a
large body of literature exploring these factors in TKR, this is the
most comprehensive study of this type in UKR.
As in previous TKR studies, pre-operative PROMs are observed
to strongly predict post-operative PROMs13,18. However, patients
with severe preoperative pre-operative disease are no less satisﬁed
following surgery despite reporting poorer PROMs. Patients with
higher preoperative PROMs are also at higher risk of being worse-
off following surgery than they were beforehand. This may be an
issue of measurement: patients with high preoperative PROMsmay
make gains undetectable by the OKS35. This is supported by the
ﬁnding that 6-month OKS and satisfaction are just as great with
patients with the highest pre-operative OKS as those with lower
values. However, caution should be exercised when offering any
form of arthroplasty to patients with very high pre-operative
function.Age has a positive effect on outcome by each metric. Whilst
OKS deteriorates with age in the general population36, in this
cohort, young patients undergoing UKR tend to have lower
baseline OKS levels than older patients, which may represent a
higher threshold for offering arthroplasty to younger patients.
However, even following adjustment for these differences, older
patients derive the greatest beneﬁt from UKR, and have lower
revision rates than younger patients. These ﬁndings, together
with the lower rates of perioperative morbidity and mortality
associated with UKR7,8, suggest that older patients fare particu-
larly well with UKR. This is contrary to current practice: UKR
comprises nearly 20% of all knee replacements performed in
patients in their ﬁfties, but only 5% in octogenarians2. Of
particular concern would appear to be younger patients with
very poor pre-operative PROMs, who appear to fare particularly
poorly in terms of OKS gain.
In this cohort, more men than women undergo UKR: 58% of
TKRs are performed in women, whilst the equivalent ﬁgure is only
46% in UKR2. Whilst men and women achieve similar PROMs and
satisfaction levels, there is a small but statistically signiﬁcant dif-
ference in 8-year survival, with men less likely to require revision.
This contrasts with TKR, where male gender is an established risk
factor for revision, despite men reporting better PROMs10,13,15,16.
The effect in TKR may be due to a higher infection rate in men; the
relative rarity of infection following UKR may account for this dif-
ference2. It is unclear whether the effect of gender on survival in
UKR is due to the fact that women are generally smaller than men
(and hence the implants used are smaller and implantation is more
technically demanding), or to some factor intrinsic to female
gender. One reason may be the higher incidence of inﬂammatory
arthropathies in women; UKRs implanted in patients with
Table IV
PROM models
Variable OKS model e continuous OKS model e binary Satisfaction
Adjusted mean difference (±95 CI) Sig. Odds ratio (±95 CI) Sig. Odds ratio (±95 CI) Sig.
Age (per year) 18e75 0.14 (0.09e0.20) <0.001 0.96 (0.94e0.98) <0.001 1.02 (1.01e1.03) <0.001
75 0.18 (0.63 to 0.07) 0.162
Gender 0.19 (0.63 to 1.02) 0.650 1.06 (0.74e1.53) 0.744 1.01 (0.86e1.18) 0.924
ASA grade 0.53 (1.35 to 0.29) 0.206 1.00 (0.70e1.44) 0.998 0.88 (0.77e1.02) 0.088
BMI Normal weight Reference 1.00 (0.96e1.05) 0.923 1.00 (0.98e1.02) 0.979
Underweight 4.42 (5.06 to 13.91) 0.360
Overweight 0.03 (1.47 to 1.42) 0.972
Obese 1.04 (2.50 to 0.41) 0.160
Ethnicity White Reference Reference Reference
Un-deﬁned 0.24 (1.08 to 1.57) 0.717 0.90 (0.46e1.75) 0.750 1.05 (0.84e1.32) 0.654
Mixed race 0.60 (7.33 to 6.12) 0.860 e e 0.65 (0.32e1.33) 0.239
Asian 9.77 (14.26 to 5.27) <0.001 1.42 (0.43e4.64) 0.564 0.41 (0.21e0.79) 0.007
Black 10.79 (19.19 to 2.75) 0.009 3.65 (0.68e19.56) 0.131 0.53 (0.29e0.99) 0.048
Other 1.92 (6.56 to 2.72) 0.428 e e 0.82 (0.47e1.44) 0.494
Unit type Public Hospital Reference Reference Reference
Private hospital 0.48 (0.76 to 1.72) 0.448 0.78 (0.43e1.41) 0.412 1.16 (0.90e1.49) 0.265
ISTC 1.09 (0.91 to 3.09) 0.286 0.26 (0.03e1.99) 0.193 1.27 (0.91e1.78) 0.154
Consultant performed 0.99 (0.25 to 2.22) 0.116 0.56 (0.35e0.91) 0.018 1.40 (1.13e1.74) 0.002
Mechanical thrombo-prophylaxis TEDs Reference Reference Reference
Foot pumps 0.88 (0.22 to 1.98) 0.117 1.01 (0.65e1.58) 0.951 1.10 (0.89e1.36) 0.362
Other 1.29 (7.22 to 4.63) 0.668 0.74 (0.09e5.86) 0.773 0.71 (0.35e1.46) 0.358
None 1.48 (3.37 to 0.41) 0.125 1.31 (0.68e2.53) 0.426 0.89 (0.67e1.18) 0.423
Chemical thrombo-prophylaxis Heparin/LMWH Reference Reference Reference
Aspirin 1.61 (2.54 to 0.25) 0.108 1.78 (1.02e3.12) 0.043 0.75 (0.55e1.01) 0.058
Warfarin 3.18 (9.92 to 3.57) 0.356 1.17 (0.23e6.01) 0.854 1.01 (0.41e2.45) 0.988
DTI 0.40 (1.19 to 1.99) 0.624 0.80 (0.36e1.77) 0.584 0.82 (0.63e1.05) 0.120
Other 0.44 (1.69 to 0.81) 0.486 0.77 (0.42e1.38) 0.375 0.93 (0.74e1.16) 0.509
None 0.93 (1.04 to 2.90) 0.356 0.83 (0.36e1.92) 0.663 1.00 (0.72e1.37) 0.985
Implant ﬁxation 0.56 (1.78 to 0.65) 0.365 1.21 (0.67e2.18) 0.530 0.81 (0.65e1.02) 0.068
Charlson co-morbidity index None Reference Reference Reference
Mild 0.71 (1.79 to 0.37) 0.198 1.01 (0.63e1.61) 0.962 1.07 (0.88e1.29) 0.498
Moderate 0.41 (2.18 to 3.00) 0.756 2.95 (1.23e7.05) 0.015 1.21 (0.66e2.22) 0.540
Severe 5.86 (0.81 to 12.53) 0.085 1.72 (0.20e15.01) 0.624 2.19 (0.77e6.19) 0.140
IMD (Quintiles) 0.93 (0.60e1.27) <0.001 0.76 (0.66e0.88) <0.001 1.07 (1.01e1.15) 0.029
Unit size (per 10 cases) Up to 40 cases 0.32 (0.05 to 0.70) 0.088 0.98 (0.95e1.02) 0.354 1.01 (1.00e1.03) 0.032
Above 40 cases 0.00 (0.07 to 0.12 0.570
Pre-operative OKS 0.24 (0.18 to 0.30) <0.001 1.10 (1.07e1.13) <0.001 1.00 (0.99e1.01) 0.807
Pre-operative EQ5D anxiety/depression None Reference Reference Reference
Moderate 0.60 (1.57 to 0.36) 0.221 1.29 (0.86e1.94) 0.220 0.97 (0.81e1.15) 0.708
Extreme 3.32 (6.16 to 0.47) 0.023 1.63 (0.52e5.11) 0.404 0.92 (0.55e1.54) 0.752
Self-reported health 1.70 (2.24 to 1.16) <0.001 1.30 (1.03e1.65) 0.027 0.58 (0.52e0.65) <0.001
Self-reported disability 2.33 (3.24 to 1.41) <0.001 1.92 (1.30e2.86) <0.001 0.82 (0.70e0.96) 0.012
Adjusted mean differences are calculated in the multivariable linear regression models; positive ﬁgures demonstrate that the variable is associated with improved outcomes,
negative ﬁgures demonstrate that the variable has a negative effect on post-operative OKS. TEDs e Thromboembolic Deterrent Stockings; LMWH e Low Molecular Weight
Heparin; DTI e Direct Thrombin Inhibitor; OKS e Oxford Knee Score; EQ5D e EuroQol 5 Domain Score. BMI is categorised for the continuous PROM outcome as it predicts
outcome in a non-linear fashion. Both satisfaction and the binary PROM outcome are predicted in a linear fashion and an overall Odds Ratio is given.
A.D. Liddle et al. / Osteoarthritis and Cartilage 22 (2014) 1241e12501246undiagnosed inﬂammatory arthritis are at higher risk of revision
secondary to disease progression. However, given the small margin
of difference in survival, and the equivalent PROMs, this study does
not provide evidence for restriction of access to UKR on the basis of
gender.
This study provides no evidence for restricting UKR on the
basis of any of the other patient factors examined. Neither BMI nor
ASA score are demonstrated to inﬂuence outcome. Whilst depri-
vation, morbidity, and anxiety/depression pre-dispose to a poor
outcome (in terms of implant survival, PROMs and satisfaction), all
are also established risk factors for poor outcomes following
TKR13,14,19,37. Likewise, whilst black and Asian patients have poorer
outcomes in terms of PROMs and satisfaction, similar differences
are observed TKR12. The reasons for these differences are
complicated and may relate to differences in social support, pain
perception and access to arthroplasty38. Black and Asian patients
may present later in the disease process and therefore have more
severe preoperative disease27. In this study, Black and Asian pa-
tients had signiﬁcantly worse preoperative OKS than whitepatients. In addition, ethnicity may affect disease pattern, which
may affect suitability for UKR4. The conclusions that can be drawn
from this study in this regard are limited by the small number of
patients in the ethnic groups which demonstrate signiﬁcantly
poorer outcomes (Black and Asian, which comprise 2.5% of the
study population collectively).
Patients have better outcomes if a consultant rather than a
trainee performs their UKR. Revision rates are lower, and satisfac-
tion rates higher, in high-volume units (supporting previous
studies of both TKR and UKR39e41). There is a large effect up to 40
cases per year, but there is a plateau above this level. This may
represent improved surgical or post-surgical care in units with
greater experience of UKR, or it may simply reﬂect the surgeons in
the unit performing a greater number of cases each and hence
gaining greater experience and expertise39,41.
Whilst NJRs consistently report poorer survival in TKR when it is
performed using cementless implants, this study demonstrates no
such effect in UKR2. This supports the view that UKR may be more
suitable for cementless ﬁxation than TKR42. Whilst implant survival
Fig. 2. LOWESS plot of age (horizontal axis) against pre-operative (solid line) post-
operative (dotted line) OKS (vertical axis) demonstrating non-linearity of the effect
of age on patient-reported outcome.
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a greater chance of deterioration with a trend to lower overall OKS
and satisfaction. This may simply be an indicator of higher levels of
pre-existing morbidity in patients receiving aspirin, but warrants
further investigation.Comparison to existing studies
Whilst many studies exist which explore the factors affecting
outcome following TKR, there are few equivalent studies in UKR.
Pandit et al. reports the effect of patient factors on survival and
PROMs (OKS, Knee Society Score (KSS) and Tegner activity scale) in
1000 UKRs, reporting signiﬁcantly superior Tegner scores in
younger and heavier patients but no differences in OKS or sur-
vival22. Thompson et al. report poorer survival in women and su-
perior KSS scores in younger and lighter patients with no
commensurate increase in revision rate43.
In a multi-centre study of 944 UKRs, Sebillo et al. reported
superior survival in older patients and men, with no differenceFig. 3. LOWESS curves of pre-operative (horizontal axis) against 6-month OKS (vertical
axis), stratiﬁed by age. Whilst all groups improve substantially, young patients with
very poor pre-operative scores are demonstrated to have a poorer level of improve-
ment when compared with other patient groups.in PROMs or satisfaction for either and no effect of BMI44. Case
series from Matharu et al. (459 UKRs), Kristensen et al. (695)
and Price et al. (564) report no statistically signiﬁcant effect of
age or gender on the revision rate45e47. Kuipers et al. (437
mobile-bearing UKRs, median follow-up 2.6 years), report a
higher risk of revision in patients under the age of 60 (Hazard
ratio (HR) 2.2, 95% CI 1.08e4.43), but no effect of gender or
BMI48.
Strengths and limitations
This study represents the most comprehensive examination of
risk factors for failure in UKR. The use of linked datasets has facil-
itated the examination of a large number of predictors. The fact that
this study used an unselected registry sample with multiple sur-
geons and implants suggests high external validity.
Limitations relate to the potential for unmeasured confounding,
particularly due to preoperative disease state49. The large amount
of missing BMI data is a concern. However, BMI did not exert an
appreciable effect on outcome in either the complete-case (see
Statistical Appendix) or imputed datasets. Only short-term
PROMs were available, and only on a subset of patients however,
the PROM patients were similar to the overall cohort (Table I),
PROMs have been demonstrated to stabilise after the ﬁrst 6 months
following surgery, and longer-term results have been presented in
the form of revision rates50. PROMs by deﬁnition provide the pa-
tient's view of their result and may vary by patient characteristics
even if ‘objective’ measures such as walking speed show similar
results.
Conclusions
This study has identiﬁed important surgical and patient factors
which affect outcome after UKR. Of note, older patients, who are
the patients least likely to be offered UKR, are those who appear to
derive the greatest beneﬁt and have the lowest revision rates.
Particular caution should be exercised in younger patients with
very low preoperative functional scores. No evidence has been
found for the use of narrow indications for UKR in terms of BMI or
ASA, and many other prognostic factors are common to both UKR
and TKR. Superior outcomes have been demonstrated for patients
operated upon by consultant surgeons in high-volume units, sup-
porting the ﬁndings of previous studies which report an important
effect of surgical experience in generating acceptable outcomes
from UKR. The information provided by this study should inform
patients and surgeonswhen decidingwhether to proceedwith UKR
in cases of end-stage osteoarthritis.
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SHR (±95 CI) Signiﬁcance HR (±95 CI) Signiﬁcance
Age (linear, per year) 0.96 (0.96e0.97) <0.01 0.96 (0.96e0.97) <0.01
Gender (male) 0.85 (0.76e0.94) <0.01 0.86 (0.76e0.96) 0.01
ASA (per one grade increase) 1.07 (0.96e1.18) 0.22 1.06 (0.95e1.20) 0.30
BMI (per unit, n ¼ 13,501) 1.01 (0.98e1.03) 0.59 1.01 (0.98e1.03) 0.59
Ethnic group e white Reference
un-deﬁned 0.86 (0.74e1.01) 0.07 0.86 (0.72e1.02) 0.08
Mixed race 0.34 (0.05e2.42) 0.28 0.34 (0.05e2.24) 0.26
Asian 0.80 (0.52e1.24) 0.32 0.81 (0.52e1.25) 0.34
Black 1.02 (0.50e2.07) 0.96 1.02 (0.50e2.06) 0.96
Other 0.39 (0.10e1.57) 0.19 0.39 (0.09e1.61) 0.19
Unit type e NHS hospital Reference
Independent hospital 1.06 (0.88e1.29) 0.53 1.07 (0.87e1.30) 0.53
ISTC 1.40 (0.96e2.03) 0.08 1.43 (0.99e2.05) 0.05
Consultant performed 0.78 (0.67e0.91) <0.01 0.78 (0.67e0.91) <0.01
Mechanical thrombo-prophylaxis TEDS Reference
Foot pumps 0.97 (0.84e1.21) 0.68 0.98 (0.81e1.19) 0.82
Other 1.22 (0.74e1.99) 0.27 1.24 (0.77e2.01) 0.37
None 1.00 (0.86e1.17) 0.96 1.01 (0.83e1.22) 0.94
Chemical thrombo-prophylaxis Heparin/LMWH Reference
Aspirin 1.10 (0.94e1.29) 0.22 1.11 (0.90e1.37) 0.34
Warfarin 0.70 (0.34e1.50) 0.36 0.71 (0.35e1.44) 0.34
DTI 0.55 (0.30e1.00) 0.05 0.55 (0.30e1.01) 0.06
Other 0.80 (0.58e1.11) 0.18 0.81 (0.59e1.11) 0.19
None 1.21 (1.04e1.41) 0.02 1.22 (0.98e1.51) 0.08
Fixation 1.02 (0.83e1.25) 0.87 1.02 (0.79e1.31) 0.89
Charlson e No comorbidities Reference
Mild comorbidities 1.13 (0.97e1.31) 0.13 1.12 (0.96e1.30) 0.16
Moderate comorbidities 1.46 (1.04e2.05) 0.03 1.49 (1.04e2.12) 0.03
Severe comorbidities 1.26 (0.63e2.53) 0.51 1.40 (0.72e2.72) 0.33
IMD (per quintile) 0.96 (0.92e1.00) 0.04 0.96 (0.91e1.00) 0.07
Unit size (per ten cases) Up to 40 cases/yr 0.99 (0.99e1.00) <0.01 0.92 (0.86e0.97) 0.01
Above 40 cases/yr 1.00 (1.00e1.00) 0.13 0.99 (0.97e1.01) 0.32
Estimates from competing risks and Cox regression models for survival. SHR e Subhazard Ratio; TEDS e Thromboembolic deterrent stockings; LMWH e Low Molecular
Weight Heparin; DTI e Direct Thrombin Inhibitor.Acknowledgements
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As a sensitivity analysis, the multivariable survival analysis
conducted in the ﬁrst part of the study was repeated, adjusting for
the competing risk of death using the method of Fine and Gray.
Only minimal differences were determined between the estimates
of the twomodels. As such the Cox model is given in the paper. The
two models are compared in the table below.Missing data: BMI.
The NJR is the only joint registry worldwide which collects data
relating to BMI. As has been noted in previous analyses of NJR data,
a large proportion of the BMI data are missing. In this instance, BMI
data are only available on 13,501 of the 25,982 records (52.0%); of
those with PROM data, this ﬁgure is 2553 of 3862 (66.1%).
Missing BMI data were explored and appear to be missing at
random.Analyseswere conducted on the complete datasetwith and
without BMI, and then the missing data were completed using MI.
MI was performed using the MI suite of commands in Stata (in
this case, using truncated regression). Ten imputed datasets were
created using all other available exposure variables and the
A.D. Liddle et al. / Osteoarthritis and Cartilage 22 (2014) 1241e1250 1249outcome variable (either the continuous OKS outcome, the
continuous satisfaction outcome or the NeilsoneAalen estimator of
survival, depending on the analysis). MI was performed separately
for each of the comparisons studied.Analysis Univariable Multivariable (complete case) Multivariable (imputed)
Survival, hazard ratio 1.02 (1.00e1.04), P ¼ 0.05 1.00 (0.99e1.02), P ¼ 0.66 1.01 (0.98e1.03), P ¼ 0.59
OKS (continuous),
coefﬁcient
Underweight 1.40 (8.50 to 11.30), P ¼ 0.78 4.34 (5.14 to 13.83), P ¼ 0.37 4.42 (5.06 to 13.91), P ¼ 0.36
Normal Reference Reference Reference
Overweight 0.03 (1.27 to 1.21), P ¼ 0.96 0.24 (1.47 to 1.42), P ¼ 0.97 0.03 (1.47 to 1.42), P ¼ 0.97
Obese 1.50 (2.74 to 0.26), P ¼ 0.02 1.13 (2.59 to 0.33), P ¼ 0.13 1.04 (2.50 to 0.41), P ¼ 0.16
OKS (binary), odds ratio 1.02 (0.98e1.06), P ¼ 0.31 1.00 (0.95e1.04), P ¼ 0.89 1.00 (0.96e1.05), P ¼ 0.92
Satisfaction, odds ratio 0.97 (0.96e0.99), P < 0.001 1.00 (0.98e1.02), P ¼ 0.99 1.00 (0.98e1.02), P ¼ 0.98References
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